We are live on ! Find out more
Axa

Axa Portfolio holdings

AUM $91.9M
1-Year Est. Return 27.41%
This Fund
S&P 500
This Quarter Est. Return
+2.56%
1 Year Est. Return
+27.41%
3 Year Est. Return
+100.68%
5 Year Est. Return
+129.89%
10 Year Est. Return
+554.73%
AUM
$23B
AUM Growth
+$654M
Cap. Flow
+$6.71M
Cap. Flow %
0.03%
Top 10 Hldgs %
15.45%
Holding
1,532
New
151
Increased
540
Reduced
484
Closed
141

Top Buys

Rank Stock Value
1
VZ icon
Verizon
VZ
+$284M
2
DB icon
Deutsche Bank
DB
+$159M
3
NSC icon
Norfolk Southern
NSC
+$108M
4
HPQ icon
HP
HPQ
+$92.2M
5
DD
Du Pont De Nemours E I
DD
+$80.9M

Top Sells

Rank Stock Value
1
LLY icon
Eli Lilly
LLY
+$161M
2
F icon
Ford
F
+$87.9M
3
WHR icon
Whirlpool
WHR
+$74M
4
PNC icon
PNC Financial Services
PNC
+$72.9M
5
EMN icon
Eastman Chemical
EMN
+$72.9M

Sector Composition

Rank Sector Weight
1 Healthcare 15.62%
2 Technology 14.22%
3 Financials 13.17%
4 Industrials 11.49%
5 Energy 8.62%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WPM icon
301
Wheaton Precious Metals
WPM
$67.5B
$14.2M 0.06%
626,206
+803
+0.1% +$18.9K
REGN icon
302
Regeneron Pharmaceuticals
REGN
$80.5B
$14.2M 0.06%
47,199
-14,510
-24% -$4.47M
PAAS icon
303
Pan American Silver
PAAS
$20B
$14.2M 0.06%
1,099,711
-5,600
-0.5% -$75K
COR icon
304
Cencora
COR
$61.5B
$14.2M 0.06%
215,821
-8,558
-4% -$582K
SSRI
305
DELISTED
Silver Standard Resources
SSRI
$14.1M 0.06%
1,420,428
-38,600
-3% -$362K
HAIN icon
306
Hain Celestial
HAIN
$53.7M
$14.1M 0.06%
308,000
-6,000
-2% -$273K
TXN icon
307
Texas Instruments
TXN
$240B
$14.1M 0.06%
298,536
-25,564
-8% -$1.13M
TCPC icon
308
BlackRock TCP Capital
TCPC
$337M
$14M 0.06%
847,115
TRI icon
309
Thomson Reuters
TRI
$45.2B
$13.8M 0.06%
346,144
+330,547
+2,119% +$13.6M
LKQ icon
310
LKQ Corp
LKQ
$6.05B
$13.7M 0.06%
520,000
+123,000
+31% +$3.44M
IAU icon
311
iShares Gold Trust
IAU
$63.7B
$13.5M 0.06%
542,780
ALGN icon
312
Align Technology
ALGN
$10.5B
$13.4M 0.06%
259,000
+21,000
+9% +$1.18M
TRP icon
313
TC Energy
TRP
$63.8B
$13.4M 0.06%
294,565
+20,564
+8% +$912K
SGEN
314
DELISTED
Seagen Inc. Common Stock
SGEN
$13.2M 0.06%
290,181
+13,030
+5% +$623K
CBST
315
DELISTED
CUBIST PHARMACEUTICALS INC
CBST
$13.1M 0.06%
179,242
+25,762
+17% +$1.92M
SAFM
316
DELISTED
Sanderson Farms Inc
SAFM
$13M 0.06%
166,231
+36,008
+28% +$2.69M
CNQ icon
317
Canadian Natural Resources
CNQ
$106B
$12.9M 0.06%
693,097
-1,016,978
-59% -$17.2M
NVDQ
318
DELISTED
Novadaq Technologies Inc.
NVDQ
$12.8M 0.06%
573,000
+7,000
+1% +$139K
GT icon
319
Goodyear
GT
$1.5B
$12.7M 0.06%
485,600
+41,000
+9% +$1.04M
SF
320
Stifel
SF
$11.6B
$12.6M 0.05%
+569,250
New +$12.1M
EFV icon
321
iShares MSCI EAFE Value ETF
EFV
$31.7B
$12.6M 0.05%
218,510
-7,000
-3% -$395K
GG
322
DELISTED
Goldcorp Inc
GG
$12.6M 0.05%
513,982
-9,584
-2% -$244K
POT
323
DELISTED
Potash Corp Of Saskatchewan
POT
$12.4M 0.05%
343,100
-58,700
-15% -$1.97M
EFG icon
324
iShares MSCI EAFE Growth ETF
EFG
$16.4B
$12.3M 0.05%
174,009
-3,000
-2% -$210K
AVY icon
325
Avery Dennison
AVY
$12.9B
$12.3M 0.05%
243,200
-17,800
-7% -$888K

Similar funds

Axa's Q1 2014 Portfolio in Review

As of Q1 2014, Axa held 1,532 positions worth $23B, up 2.9% from $22.3B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Axa's Q1 2014 filing shows 151 new, 540 increased, 484 reduced and 141 closed positions. Its largest new stake was Celanese: 949,936 shares worth $52.7M. The largest sale was Eli Lilly, an estimated $161M.

By sector, the portfolio is most concentrated in Healthcare at 16% of assets, down from 16% a quarter earlier, followed by Technology and Financials.

  • Axa's largest Q1 2014 buy was Celanese: 949,936 shares worth $52.7M.
  • Axa added most to Verizon in Q1 2014, an estimated $284M increase.
  • Axa's biggest Q1 2014 reduction was Eli Lilly, cutting an estimated $161M.
  • Axa fully exited Avon Products, Inc. in Q1 2014, selling an estimated $53.7M.
  • Axa's ten largest holdings make up 15% of its $23B portfolio in Q1 2014.
  • Axa opened 151 new positions and closed 141 in Q1 2014.
  • Axa's portfolio value rose 2.9% quarter-over-quarter to $23B.

Based on Axa's 13F filing for Q1 2014, filed 13 May 2014.